EU urged to exempt drugs from BSE rules - Farmers Weekly

Subscribe and save

Farmers Weekly from £129
Saving £36
In print AND tablet

SUBSCRIBE NOW

sub_ad_img

EU urged to exempt drugs from BSE rules

09 September 1997
EU urged to exempt drugs from BSE rules

EUROPEAN Union scientists have advised that pharmaceuticals and cosmetics could be exempted from new safety rules intended to curb the spread of bovine spongiform encephalopathy (BSE). This would avert a potential shortage of medicines in Europe and a trade row with the US.

The new rules ban tallow and its derivatives, used in an estimated 80% of pharmaceuticals, from January.

There is now likely to be a formal proposal that pharmaceuticals and cosmetics containing derivatives that have been heat-treated, according to one of three approved methods, should be exempted.

But up to 80% of capsules are believed to contain derivatives of gelatine. It is less clear-cut how these can be guaranteed BSE-free.

  • Financial Times 09/09/97 page 8

  • US warns EU over meat safety rules, FWi, yesterday (September 8)

    • Read more on:
    • News

    EU urged to exempt drugs from BSE rules

    09 September 1997
    EU urged to exempt drugs from BSE rules

    EUROPEAN Union scientists have advised that pharmaceuticals and cosmetics could be exempted from new safety rules intended to curb the spread of bovine spongiform encephalopathy (BSE). This would avert a potential shortage of medicines in Europe and a trade row with the US.

    The new rules ban tallow and its derivatives, used in an estimated 80% of pharmaceuticals, from January.

    There is now likely to be a formal proposal that pharmaceuticals and cosmetics containing derivatives that have been heat-treated, according to one of three approved methods, should be exempted.

    But up to 80% of capsules are believed to contain derivatives of gelatine. It is less clear-cut how these can be guaranteed BSE-free.

  • Financial Times 09/09/97 page 8

    • Read more on:
    • News
    blog comments powered by Disqus